Guías para el manejo y tratamiento de los síndromes coronarios agudos en terapia Intensiva y Unidades de Emergencias.
PDF

Palabras clave

sindromes coronarios agudos
complicaciones
arritmias.

Cómo citar

1.
Flores LA. Guías para el manejo y tratamiento de los síndromes coronarios agudos en terapia Intensiva y Unidades de Emergencias. Rev Arg de Ter Int. [Internet]. 13 de julio de 2010 [citado 6 de junio de 2020];27(1). Disponible en: //revista.sati.org.ar/index.php/MI/article/view/29

Resumen

Complicaciones Arrítmicas y de la conducción en la fase aguda del SCACEST:Parte VII: Arritmias Supraventriculares y Ventriculares.IntroducciónLas arritmias y los trastornos de conducción son frecuentes en el SCACEST, hasta un 90 % de los pacientes presentan algún trastorno del ritmo. Generalmente aparecen en forma precoz, son potencialmente fatales y requieren de resolución inmediata. Su aparición influye en el pronóstico precoz  y tardío.
PDF

Citas

BIBLIOGRAFIA

 

[1]  Karagueuzian HS, Mandel WJ, et al. Electrophysiologic mechanisms of ischemic ventricular arrhythmias: experimental and clinical correlations. In Mandel WJ, ed. Cardiac arrhythmias: their mechanisms, diagnosis, and management. Philadelphia, PA: JB Lippincott; 1995:563- 603.

 

[1] Carmeliet E. Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol Rev 1999; 79: 917-1017.

 

[1] Waldo AL. An approach to therapy of supraventricular tachyarrhythmias: an algorithm versus individualized therapy. Clin Cardiol 1994; 17:II 21-6.

 

[1] Ganz LI, Friedman PL: Supraventricular tachycardia. N Engl J Med 1995; 332: 162-173.

 

[1] Atman EM, Anbe DT, Armstrong PW, ACC/AHA Guidelines For the Management of Patients With ST- elevation Myocardial Infarction: A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for the Management of Patients With Acute Myocardial Infarction.) J Am Coll Cardiol 2004; 44: E1 – 211.

 

[1] Werf V., Bax J., Betriu A , et al. Guías de Práctica Clínica de la Sociedad Europea de Cardiología (ESC). Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segmento ST. Rev Esp Cardiol. 2009; 62 (3):e1-e47

 

[1] Berger PB, Ruocco NA Jr, Ryan TJ, y col. Incidente and prognostic implications of heart block complicating inferior myocar-dial infarction treated with thrombolytic therapy: results from TIMI-II. J Am Coll Cardiol. 1992; 20: 533-540.

 

[1] Crenshaw BS, Ward SR, Granger CB, et al. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol 1997; 30:406-13.

 

[1] Pedersen OD, Bagger H, Køber L, Torp-Pedersen C, for the TRAndolapril Cardiac Evaluation (TRACE) Study Group. The occurrence   and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. Eur  Heart J 1999; 20:748-54.

 

[1] . Wong CK, White HD, Wilcox RG, et al. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. Am Heart J 2000; 140:878-85.

 

[1] Behar S, Zahavi Z, Goldbourt U, et al. For the SPRINT Study Group. Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. Eur Heart J 1992; 13:45-50.

 

[1] Joglar JA, Hamdan MH, Ramaswamy K, et al. Initial energy for elective external cardioversion of persistent atrial fibrillation. Am J Cardiol 2000; 86:348-50.

 

[1]  Dahl CF, Ewy GA, Warner ED, Thomas ED. Myocardial necrosis from direct current countershock. Effect of paddle electrode size and time interval between discharges. Circulation 1974;50:956- 60

 

[1] Moss AJ, Oakes D, Benhorin J, Carleen E, for the Multicenter Diltiazem Post-Infarction Research Group. The interaction between diltiazem and left ventricular function after myocardial infarction. Circulation  1989;80:IV102-6.

 

[1] Wong CK, White HD, Wilcox RG, et al, for the GUSTO-III Investigators. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries. Heart 2002; 88:357-62.

 

[1] Fuster V, Rydén LE, Cannom DS, Crijns HJ, et al. ACC/ AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Eur Heart J.  2006;  27:1979- 2030.

 

[1] Karagueuzian HS, Mandel WJ. Electrophysiologic mechanisms of ischemic ventricular arrhythmias: experimental and clinical correlations. In Mandel WJ, ed. Cardiac arrhythmias: their mechanisms, diagnosis, and management. Philadelphia, PA: JB Lippincott; 1995:563-603.

 

[1] .Gheeraert PJ, Henriques JP, De Buyzere ML, et al: Our-of-hospital ventricular fibrillation in patients with acute myocardial infarction: Coronary angiographic determinants. J Am Cardiol 2000; 35: 144-150.

 

[1] Volpi A, Cavalli A, Santoro E, Tognoni G, for the GISSI Investigators. Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarction: evidence for a protective effect of thrombolytic therapy. Circulation 1990; 82:1279-88.

 

[1] Campbell RWF, Murray A, Julian DG: Ventricular arrhythmias in first 12 hours of acute myocardial infarction: Natural history study. Br Heart J 1981; 46: 351-357.

 

[1] Newby KH, Thompson T, Stebbins A, y col: Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: Incidence and outcomes. The GUSTO Investigators. Circulation 1998; 98: 2567-2573.

 

[1] Bono J, Fernandez Cid G, Flores L. Protocolo del IAM complicado (parte 1 –2), Medicina Intensiva 1998; Vol 15 Nº 2 40 – 47.

 

[1] Volpi A, Cavalli A, Santoro E, Tognoni G, for the GISSI Investigators. Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarction: evidence for a protective effect of thrombolytic therapy. Circulation 1990;82:1279-88.

 

[1] Ornato JP, Peberdy MA, Tadler SC, Strobos NC. Factors associated with the occurrence of cardiac arrest during hospitalization for acute myocardial infarction in the second national registry of myocardial infarction in the US. Resuscitation 2001;48:117-23.

 

[1]  Hazinski MF, Hickey R, Billi J, et al. American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2005 112 (suppl I): IV 19 – 46; IV 58 –77.

 

[1] MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomized, controlled trials. JAMA 1988;260:1910-6.

 

[1] Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999;341:871-8.

 

[1] Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002;346:884-90.

 

[1] Zipes DP, Camm AJ, Borggrefe M, et al. Guías de Práctica Clínica ACC/AHA/ESC 2006 para el manejo de pacientes con arritmias ventriculares y la prevención de la muerte cardíaca súbita – resumen ejecutivo: un informe del Grupo de Trabajo del American College of Cardiology/American Heart Association y del Comité de Guías de Práctica Clínica de la Sociedad Europea de Cardiología (Comité para el Desarrollo de Guías de Práctica Clínica para el Manejo de Pacientes con Arritmias Ventriculares y la Prevención de la Muerte Cardiaca Súbita). Eur Heart J 2006; 27:2099-2140.

La revista no retiene los derechos de reproducción (copyright) por lo que los autores pueden volver a publicar sus trabajos con la sola mención a la fuente original de publicación.